The 0.06x price-to-sales multiple would be extraordinary for a business generating roughly $4B of annual revenue, but it flatters a company whose enterprise value is dominated by roughly $5.8B of debt rather than equity, so the multiple mostly prices the debt claim, not the shares. The 9.11x forward EV/EBITDA versus 10.38x trailing suggests consensus expects modest EBITDA improvement, consistent with the positive operating income prints of 2025Q4 through 2026Q2, but the 20.5x P/FCF ratio signals that equity holders are paying meaningfully for cash flow that prior analysis showed is volatile and working-capital dependent. Investors should treat the headline cheapness skeptically until net income turns durably positive.

The 58–60% gross margin band (ex the 48.4% 2026Q1 anomaly) indicates the core radio and podcast revenue base retains attractive unit economics, but the consistent collapse to single-digit or negative operating margins points to a fixed cost structure and depreciation load that scale cannot easily absorb at flat revenue. True earning power is better measured at the operating line, which has turned positive in five of the last ten quarters, than at the net line, where interest expense on the debt stack has produced nine loss-making quarters. Adjusting for the apparent ~$910M non-cash impairment embedded in 2024Q2, the underlying trajectory looks less catastrophic but still structurally sub-scale versus the interest burden.

The pattern of ROIC readings clustered around zero, with the only meaningful excursion being the -14.3% impairment-distorted 2024Q2, suggests this is not a business compounding returns but one treading water; the positive prints of 1.7–1.9% in 2025Q4 and 2024Q4 appear tied to seasonal fourth-quarter advertising strength rather than a durable efficiency gain. ROE is uninformative here given negative book equity of roughly -$2.0B, so ROIC and ROA (currently -1.7%) carry the analytical weight. The modest improvement from -2.2% in 2025Q3 to 0.7% tracks margin recovery, not asset productivity, since asset turnover has stayed pinned in the 0.12–0.21 range.

Coverage has been chronically sub-one: ten-quarter interest coverage readings range from -0.45x to 1.98x with a median below 0.6x, implying that in most periods reported operating cash flow does not fully service cash interest without drawing on cash balances or working capital timing. The D/EBITDA trend tells the same story from the other side—improving from 87.7x in 2025Q1 to 50.6x in 2026Q2, but only because EBITDA recovered modestly against a nominally static debt figure. Refinancing risk appears material: with equity wiped out at -$2.0B and debt-to-assets above 118%, any tightening of lender appetite or further EBITDA decline could force restructuring outcomes that the equity would absorb, which is what the negative P/E arguably reflects.

The DSO compression of roughly 30 days over ten quarters is a genuine operational improvement and aligns with the working capital source of cash seen in 2025Q4, though the volatile swings—from 101 days in 2025Q1 back to 92 in 2026Q1—suggest this discipline is inconsistent quarter to quarter rather than systemic. The rising asset turnover, however, is partly an artifact of the shrinking balance sheet (goodwill writedowns and PPE decline to $992.6M) rather than revenue growth, so it overstates genuine productivity gains. The rising DPO from the 48–52 range to 65 days in 2026Q2 hints that suppliers may be extending terms, a dynamic that warrants monitoring as a possible signal of negotiating leverage or, less charitably, of stretched vendor payment capacity.